Results indicate that all tested CRC cell lines expressed similarly low levels of Gas6 independent of their mutational status (i.e. KRAS, p53, BRAF and PIK3CA) (Figure 2A) (Supplementary Table S4). This evidence concerns the gene KRAS and colorectal carcinoma.